Literature DB >> 12385915

Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction.

W A Scheepens1, M M G J Jongen, F H M Nieman, R A de Bie, E H J Weil, P E V van Kerrebroeck.   

Abstract

OBJECTIVES: To investigate data from 211 patients who underwent a trial stimulation (percutaneous nerve evaluation [PNE]) to determine the clinical parameters that can enhance the prediction of PNE success. The advantageous effect of sacral neuromodulation depends on the accurate identification of suitable candidates during the preimplantation PNE.
METHODS: A total of 211 patients (161 women and 50 men), with refractory urge incontinence, urgency-frequency syndrome, and urinary retention, underwent a PNE. Patient data (demographics, medical history, urologic investigations, and diagnosis) were collected. The PNE results were evaluated from a voiding diary and patient history. More than 50% improvement of voiding parameters was considered a successful PNE, and those patients were selected for implantation. Logistic regression analysis was performed. The factors tested for predicting the test result were sex, patient age, diagnosis, previous surgery, neurogenic bladder dysfunction, duration of complaints, and previous treatments.
RESULTS: The PNEs were positive in 85 patients (40.3%) and negative in 105 patients (49.8%). In 18 patients (8.5%), the test electrode had migrated; 3 more patients were not assessable and were also excluded. Missing data on the variable "duration of complaints" reduced the number of patients in the analyses from 190 to 174 patients.
CONCLUSIONS: Intervertebral disk prolapse, duration of complaints, neurogenic bladder dysfunction, and urge incontinence were found to be significant predictive factors. However, a PNE remains necessary to evaluate a patient's chance of implant success objectively.

Entities:  

Mesh:

Year:  2002        PMID: 12385915     DOI: 10.1016/s0090-4295(02)01841-1

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

Review 1.  A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction.

Authors:  Ash K Monga; Michael R Tracey; Jeyakumar Subbaroyan
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

Review 2.  Sacral neuromodulation for lower urinary tract dysfunction.

Authors:  Philip E V Van Kerrebroeck; Tom A T Marcelissen
Journal:  World J Urol       Date:  2011-10-12       Impact factor: 4.226

3.  Mechanical reconfiguration mediates swallowing and rejection in Aplysia californica.

Authors:  Valerie A Novakovic; Gregory P Sutton; David M Neustadter; Randall D Beer; Hillel J Chiel
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2006-04-04       Impact factor: 1.836

4.  Early versus late sacral neuromodulation and systematic reviews.

Authors:  Sender Herschorn
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

Review 5.  Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis.

Authors:  Federica Puccini; Alka Bhide; Suzy Elneil; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2015-07-09       Impact factor: 2.894

6.  Comparison of patients undergoing a two-stage sacral nerve stimulation procedure: is there a cost benefit for a single-stage procedure?

Authors:  Dmitriy Nikolavsky; Kim Killinger; Judith Boura; Kenneth Peters
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

7.  Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?

Authors:  Apostolos Apostolidis
Journal:  World J Urol       Date:  2019-06-03       Impact factor: 4.226

8.  The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.

Authors:  Ranjana Jairam; Jamie Drossaerts; Gommert van Koeveringe; Philip van Kerrebroeck
Journal:  Urol Int       Date:  2017-05-06       Impact factor: 2.089

9.  Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.

Authors:  Holly E Richter; C L Amundsen; S W Erickson; J E Jelovsek; Y Komesu; C Chermansky; H S Harvie; M Albo; D Myers; W T Gregory; D Wallace
Journal:  J Urol       Date:  2017-05-10       Impact factor: 7.450

Review 10.  The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.

Authors:  A Tubaro; F Puccini; C De Nunzio; G A Digesu; S Elneil; C Gobbi; V Khullar
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.